Danaher Corporation (NYSE:DHR) is a stock that Jim Cramer has a bittersweet relationship with. His trust has continued to ...

We recently published 10 Stocks Jim Cramer Talked About As He Said Everyone Won From Trump’s Japan Deal. Danaher Corporation ...

Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer shed light on. While discussing the stock’s condition over the past couple of years, Cramer showed a positive sentiment toward the stock, ...

Danaher Corporation thrives on bioprocessing demand and diagnostics resilience. Click for why, with solid execution and 80% ...

Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Matthew Gugino, currently Group Chief Financial Officer of the Company's Life Sciences ...

Danaher Corporation (NYSE:DHR) is one of the best strong buy healthcare stocks to buy now. On July 23, UBS lowered the firm’s ...

Danaher (NYSE:DHR) stock falls even as the company beats Q2 2025 forecasts despite an underperformance at its Life Sciences ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Danaher ( (DHR) ) has issued an update.

Danaher reported generating $1.1 billion in free cash flow during the quarter, with adjusted diluted net earnings per share increasing by approximately 5% year-over-year. This financial strength ...

Danaher Corporation (NYSE:DHR) ranks among the best non-tech stocks to buy according to billionaires. On July 11, Scotiabank ...

Danaher Corporation (NYSE:DHR) is a leading global life sciences and diagnostics innovation company. With a focus on science and technology, the company helps discover, develop, and deliver ...

Danaher India partners with THSTI to enhance biomanufacturing, life sciences, and healthcare solutions in India, focusing on training, co-development, and technology access.